Effects of synthetic colloid and crystalloid solutions on hemorheology  and in hemorrhagic shock by unknown
EUROPEAN JOURNAL 
OF MEDICAL RESEARCH
Chen et al. European Journal of Medical Research  (2015) 20:13 
DOI 10.1186/s40001-015-0088-6RESEARCH Open AccessEffects of synthetic colloid and crystalloid
solutions on hemorheology in vitro and in
hemorrhagic shock
Gan Chen, Jingxiang Zhao, Penglong Li, Xuemei Kan, Guoxing You, Ying Wang, Yujing Yin, Xin Luo, Yuhua Zhang,
Lian Zhao* and Hong Zhou*Abstract
Background: Plasma expanders are commonly used in the management of critically ill patients, which may exhibit
altered hemorheology. We evaluated the effects of various synthetic colloids and Lactated Ringer’s (LR) solution on
hemorheological parameters in vitro and in a rodent hemorrhagic shock model.
Methods: For the in vitro experiments, rat blood was incubated with hydroxyethyl starch (HES) 130/0.4, HES
200/0.5, succinylated gelatine (GEL), or LR at various ratios. The control consisted of blood without dilution. The
hemorheological parameters were measured after a 15-min incubation. For the in vivo study, rats were subjected to
a severe volume-controlled hemorrhage and were resuscitated using a colloid solution (HES 130/0.4, HES 200/0.5, or
GEL) or LR. The hemorheological parameters were measured 2 h after resuscitation.
Results: The GEL significantly elevated the plasma viscosity compared to the other groups. In the in vitro study, GEL
and LR accelerated the erythrocyte aggregation. There was no significant difference between HES 130/0.4, HES
200/0.5, and control groups regarding the aggregation amplitude and index. In the in vivo study, the aggregation
amplitude increased significantly in the GEL group compared to the HES 130/0.4, HES 200/0.5, LR, and sham groups.
There was no significant difference between the groups with respect to the elongation index in vivo.
Conclusions: Hydroxyethyl starch did not change the erythrocyte aggregation compared to the control. GEL
significantly accelerates the erythrocyte aggregation and elevates the plasma viscosity compared to hydroxyethyl
starch. The in vitro hemorheological measurements most likely provide hints for the in vivo study.
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The administration of plasma expanders is crucial for
managing critically ill patients across a range of clinical
conditions, including major surgery, hemorrhagic shock
(HS), and trauma [1]. There is growing evidence that
plasma expanders, which are often given in large volumes
during fluid therapy, are associated with altered hemor-
heological parameters, which play an important role in
modulating microcirculatory and tissue oxygenation [2,3].
Previous studies have demonstrated the effects of various
fluids on hemorheology [4-7]. Dextran increased the
plasma viscosity and induced erythrocyte aggregation* Correspondence: zhaolian@bmi.ac.cn; zhouhtt1966@163.com
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unless otherwise stated.by forming dextran bridges between the cells [8,9].
Hydroxyethyl starch (HES) 450/0.7 infusion elevated
blood viscosity and erythrocyte aggregation while de-
creasing the erythrocyte deformability [6]. Gelatin was
also found to increase erythrocyte aggregation [10].
However, direct comparisons of the hemorheological
effects between plasma expanders, such as succinylated
gelatin, HES 130/0.4, HES 200/0.5, and Lactated Ringer’s
(LR) solution, are lacking. Among the hemorheological
parameters, erythrocyte aggregation may be associated
with tissue perfusion [11,12]. However, the effects of HES
on erythrocyte aggregation remain controversial [4]. HES
200/0.5 and HES 130/0.4 were indicated to induce
erythrocyte aggregation in both in vitro and in vivo
studies [6,13,14]. However, other studies have shownhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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presence of HES 200 compared to that observed in the
control group [4,15].
The rheological measurements can be investigated
in vitro and in vivo. In vitro techniques could permit
screening of the rheological properties of different plasma
expanders, such as hemoglobin-based oxygen carriers, by
mixing erythrocytes and expanders in different ratios [16].
Moreover, the in vitro rheological effects of different
solutions can be examined in normal and septic blood
to predict further compromise in vivo [6]. In vitro
rheological measurements show advantage in saving
time and animal models. However, the in vitro rheological
effects may differ significantly from the in vivo effects.
The extent to which in vitro findings for hemorheological
parameters are of relevancy for the in vivo situation needs
to be further investigated.
Thus, to evaluate the effects of synthetic colloids and LR
solution on hemorheology and the relationship between
in vitro and in vivo rheological measurements, we com-
pared HES 130/0.4, HES 200/0.5, succinylated gelatin, and
LR to demonstrate their relative effects on hemorheology
in vitro. Next, we verified the in vitro results using a ro-
dent HS model in vivo. The hemorheological parameters




This study was approved by the ethics committee of the
Institute of Transfusion Medicine, Academy of Military
Medical Sciences. All efforts were made to minimize the
number of animals used and their suffering. Fourty-eight
male Wistar rats weighing 210–250 g (Vital River Labora-
tories, Beijing, China) were included in the study; 39 rats
were used for the in vivo experiment. The remaining rats
were used for the in vitro experiment. Animals were used
after a minimum 5- to 7-day acclimation period.
The rats were anesthetized using sodium pentobarbital
(50 mg/kg), which were injected intraperitoneally. Rats
were allowed to breathe room air spontaneously in a
supine position for the duration of the experiment. Body
temperature was maintained at 37°C ± 0.1°C with the aid
of a heating pad (Softron Beijing, Inc., TMS-201, China).
The right femoral artery and vein were isolated with
minimal dissection and catheterized using polyethylene
catheters (PE-50) containing heparinized saline. Rats were
heparinized with 400 U/kg heparin (IV). Supplementary
doses of pentobarbital were administered when necessary.
Blood sampling and treatment for the in vitro study
Fresh blood samples were obtained from the right femoral
arterial catheter using heparin-treated tubes (15 U/mL).
The rat blood was centrifuged for 5 min at 1,500 × g andadjusted to a hematocrit of 40% by adding or removing
autologous plasma. To represent the clinically relevant
colloid plasma peak levels reported in the literatures
[9,17,18], the well-distributed erythrocyte samples were
subsequently diluted with 6% HES 130/0.4 (HES 130)
(Voluven®, Fresenius-Kabi, Bad Homburg, Germany), 6%
HES 200/0.5 (HES 200) (HAES-steril®, Fresenius-Kabi,
Beijing, China), 4% succinylated gelatin (GEL, 30 kDa)
(Gelofusine®, B. Braun, Shenyang, China), or LR (Juneng,
Siping, China); the volume ratios of blood with the test so-
lutions are 5:1 and 3:1. The control group consisted of the
erythrocyte suspension without dilution.
All samples were incubated for 15 min at 37°C, and
then, blood samples were adjusted to a hematocrit of
40% before measuring the hemorheological parameters.
The plasma was obtained using centrifugation to detect
the viscosity. All rheological measurements were carried
out at a temperature of 37°C, which are in accordance
with the international guidelines for the measurement of
hemorheological parameters [19].
Hemorrhagic shock/resuscitation protocol for the
in vivo study
A rat HS model was prepared as described previously [20].
After surgical preparation and 10 min of stabilization, a
volume-controlled hemorrhage of 18 mL/kg was performed
using pumps (Softron Beijing, Inc., Beijing, China) for 30
min through the right femoral arterial catheter. Rats were
then subjected to a slower hemorrhage of 12–15 mL/kg for
35 min. Due to the individual differences of animals, the
blood withdrawal rate changed with a certain range. The
animals with a base excess of −9 to −12 mmol/L were re-
suscitated after blood withdrawal via the femoral venous
catheter. The results of arterial blood gas analysis have been
published in our previous study [20].
After the volume-controlled hemorrhage was induced,
the animals were randomly assigned to one of five
groups. The sham group underwent all instrumentation
procedures without blood collection (n = 7). The other
four groups each received a different colloid solution
(HES 130, HES 200, GEL) or LR (n = 8/group). The vol-
ume of resuscitation for the colloid solutions was equal
to that of the blood withdrawal and three times that of the
blood withdrawal for LR; all the infusions were performed
using a pump-driven constant infusion at a rate of 0.33
mL/min. After 2 h had elapsed following resuscitation,
blood samples were collected from the femoral artery
with heparin-treated tubes for hemorheological evalu-
ation (15 U/mL). The animals were then euthanized by
exsanguination under anesthesia.
Hemorheological evaluation
Hemorheology was assessed through the plasma vis-
cosity, erythrocyte deformability (elongation index (EI)),
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tude (AMP).
The plasma viscosity was measured using a capillary
viscometer at 37°C (LBY-N6B, Precil Company, Beijing,
China). The measurement of viscosity was based on ana-
lyzing the capillary pressure-driven movement of plasma
whose mean velocity and, therefore, shear rate varies
with time.
EI was measured at shear rates of 100, 400, 600, 800,
and 1,000 s−1 using an ektacytometer based on laser
diffraction at 37°C (LBY-BX, Precil Company, Beijing,
China). For this purpose, a 40-μL blood sample was
suspended in 1 mL of a highly viscous solution of poly-
vinylpyrrolidone (PVP, MW = 30 kDa) in an isotonic
phosphate buffer base (pH 7.4). The EI was obtained
based on laser diffraction patterns at user-defined
shear stress values.
For the erythrocyte aggregation measurement, the
ektacytometer (LBY-BX, Precil Company, Beijing, China)
was employed. The measurement was based on the
change in back-scattered light on abrupt cessation of the
erythrocyte suspension (600 to 0 s−1) at 37°C [5,21].
After mixing 500-μL blood and 100-μL PVP buffer as
described above, a 500-μL mixture was used to measure
the aggregation parameters, including AI and AMP.
Hyperaggregation is indicated by increased AI and AMP.
Statistical analysis
Data are expressed as the mean ± standard deviation
(SD) and were examined for normal distribution and
homogeneity of variance using the Shapiro-Wilk test and
Levene’s test. The means of each group were compared
using one-way analysis of variance (ANOVA) followed by
the Student-Newman-Keuls test when the normality and
homogeneity of variance assumptions were satisfied;
otherwise, ANOVA followed by Student-Newman-Keuls




The plasma viscosity measurements in vitro are pre-
sented in Figure 1A. The plasma viscosity was signifi-
cantly increased in the presence of GEL, HES 130,
and HES 200 compared to that of the control group
(P < 0.05). The plasma viscosity levels were signifi-
cantly higher in the GEL, HES 130, and HES 200
groups compared to that in the LR group (P < 0.05).
The plasma viscosity in the HES 200 group was lower
than that in the GEL group (P < 0.05). Moreover,
there was no significant difference between the values
in the HES 130 and HES 200 groups.
Plasma viscosity increased significantly after the infu-
sion of GEL (P < 0.05) and decreased significantly afterthe infusion of HES 130, HES 200, and LR compared to
the sham group in vivo (P < 0.05, Figure 1B). The plasma
viscosity levels were significantly higher in the GEL,
HES 130, and HES 200 groups compared to that in the
LR group (P < 0.05). There was no significant difference
between the values in the HES 130 and HES 200 groups.
To confirm whether the alterations in plasma viscosity
were the result of a direct effect of the intrinsic viscosities
of the infused solutions, we performed viscosity measure-
ments of the plasma expanders. The viscosities increased
in the following order: LR <GEL <HES 130 <HES 200
(Table 1).
Erythrocyte deformability
For the ratio of 3:1, the erythrocyte deformability, as
measured using EI, significantly decreased in the presence
of the four plasma expanders at a shear rate of 100 s−1
(P < 0.05). However, the EI values at high rates (>100 s−1)
did not differ significantly among the groups (Figure 2A).
For the ratio of 5:1, there were no significant differences
among the groups at the various shear rates (Figure 2B).
In the in vivo study, the EI values at various shear rates for
the study groups were not significantly different from
those of the sham group (Figure 2C).
Erythrocyte aggregation
The in vitro erythrocyte aggregation measurements are
presented in Figure 3. For the ratio of 3:1, GEL induced
hyperaggregation by significantly increasing the AI and
AMP compared to those of the control group. AI was
significantly lower in the HES 130 and HES 200 groups
compared to that of the GEL group (P < 0.05); AMP was
significantly lower in the HES 200 group compared to
that of the GEL group (P < 0.05). There were no signifi-
cant differences among the HES 130, HES 200, and con-
trol groups with respect to AI and AMP (P > 0.05); AI
was significantly lower in the HES 200 and HES 130
groups compared to that of the LR group (P < 0.05). For
the ratio of 5:1, GEL induced a dramatic elevation in
AI and AMP compared to those of the control group
(P < 0.05). The AI and AMP were significantly lower in
the HES 200 group compared to those in the GEL
group (P < 0.05). There were no significant differences
among the HES 130, HES 200, and control groups with
respect to AI and AMP; AI was significantly lower in
the HES 200 and HES 130 groups compared to that in
the LR group (P < 0.05, Figure 3A, B). In addition, there
were no differences for AI among the various ratios.
The AMP values in the HES 130 and HES 200 groups for
the ratio of 3:1 were significantly increased compared to
those for the ratio of 5:1 (P < 0.05, Figure 3A, B).
There were no significant differences among the
groups with respect to the AI values in vivo (Figure 4A).
GEL induced a significant elevation in AMP compared
Figure 1 Effects of various plasma expanders on the plasma viscosity. (A) Plasma viscosity at various mixing ratios in vitro (n = 5). (B) Plasma
viscosity in vivo. Data are plotted as the means ± SD. &P < 0.05 versus the sham or control group; *P < 0.05 versus the LR group; #P < 0.05 versus
the GEL group.
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AMP values in the HES 130 and HES 200 groups were
significantly lower than that of the GEL group (P < 0.05).
There were no significant differences among the HES
130, HES 200, LR, and sham groups with respect to
AMP (Figure 4B).
Discussion
Different fluids under clinical conditions have been found
to cause different hemorheological effects, which may
contribute to the persistence or deterioration of the
physiological state [7,22]. The current study was con-
ducted to investigate the influence of synthetic colloids
(HES 130, HES 200, and GEL) and LR on plasma viscosity,
erythrocyte aggregability, and erythrocyte deformability
in vitro and in a rodent model of controlled hemorrhage
in vivo.
The hemorheological parameters greatly influence
blood circulation [23]. In rat spinotrapezius muscle, Kim
et al. demonstrated that induction of erythrocyte aggrega-
tion using dextran 500 at a lower arterial pressure reduces
the functional capillary density, which is an important in-
dicator of microcirculatory dysfunction [24]. Enhanced
erythrocyte aggregation may be associated with decreased
wall shear stresses and results in the suppression of
nitric oxide release, which plays a key role in the controlTable 1 Intrinsic viscosity of the four plasma expanders
LR GEL
Intrinsic viscosity (mPa.s) 0.673 ± 0.002 1.441
Values are means ± SD.
*P < 0.05 versus LR, §P < 0.05 versus HES 200, #P < 0.05 versus GEL.of circulatory function [25,26]. Furthermore, O2 release
from erythrocytes to tissues are physiologically important;
erythrocyte aggregation is one of several important factors
affecting O2 release in microvessels [27,28]. Restoring the
rheological properties of the blood by enhancing the
plasma viscosity is beneficial for maintaining the systemic
and microhemodynamic parameters during a state of
hypovolemic shock [29].
The main finding was the markedly different effects
of the buffered and non-buffered solutions on red blood
cell aggregation, both in vitro and in a rodent model of
controlled hemorrhage in vivo. At the doses used in
these experiments, we found that HES 130 and HES 200
did not change erythrocyte aggregation compared to the
control. GEL had a potent hyperaggregating effect on rat
erythrocyte. Erythrocyte aggregation in the GEL and LR
groups was significantly higher compared to those in the
HES 130 and HES 200 groups, according to the in vitro
study. In the HS model, GEL markedly increased the
aggregation amplitude compared to HES 130 and HES
200. However, there was no difference in the aggregation
index among the groups. These results are not consistent
with previous observations for HES 200 [6,13]. Earlier re-
ports suggested the HES 200 may affect normal erythro-
cyte rheology. Henkelman et al. demonstrated that HES
200/0.5 enhanced erythrocyte aggregation in vitro using aHES 200 HES 130
± 0.015* 1.797 ± 0.013#* 1.529 ± 0.015#*§
Figure 2 Effects of various plasma expanders on erythrocyte deformability. (A) Erythrocyte deformability at a ratio of 3:1 in vitro (n = 5).
(B) Erythrocyte deformability at a ratio of 5:1 in vitro (n = 5). (C) Erythrocyte deformability in vivo. Data are plotted as the means ± SD. &P < 0.05
versus the control group.
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Figure 3 Effects of various plasma expanders on erythrocyte aggregation in vitro. (A) AI at various mixing ratios (n = 5). (B) AMP at various
mixing ratios (n = 5). Data are plotted as the means ± SD. &P < 0.05 versus the control group; *P < 0.05 versus the LR group; #P < 0.05 versus the
GEL group; §P < 0.05 versus the ratio of 3:1.
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ences in the concentration of colloid may account for
these controversial results. In this study, erythrocyte ag-
gregation was tested on erythrocytes suspended in 10%
200-kDa HES solutions. The final concentration of HES
is higher than that of our present study (1% and 1.5%). It
has been shown that the aggregation of erythrocytes was
extended and accelerated by increasing the concentration
of HES [13]. In contrast, our results for HES were consist-
ent with a report of preoperative hemodilution [4]. The
erythrocyte aggregation was unchanged with HES 200 in
the study.Figure 4 Effects of various plasma expanders on erythrocyte aggrega
plotted as the means ± SD. &P < 0.05 versus the sham group; *P < 0.05 versuIn this study, the ability of erythrocytes to form
aggregates was measured by the aggregation amplitude
and aggregation index. The prominent effect observed
in vitro is in accordance with in vivo data for aggregation
amplitude. However, the data for aggregation index in
the in vitro study is not in accordance with the in vivo
data. Our results revealed this incongruence between the
in vivo and in vitro studies. The aggregation amplitude
represents the extent of the aggregation. The overall
aggregation behavior of the suspension is described by
the aggregation index. The aggregation amplitude may
be more sensitive than the aggregation index. It hastion (AI and AMP) in vivo. (A) AI in vivo. (B) AMP in vivo. Data are
s the LR group; #P < 0.05 versus the GEL group.
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nificantly higher in patients with slow coronary flow,
whereas there was no significant difference between
the groups with respect to the aggregation index [30].
In another study, Hazer et al. demonstrated the effect
of pravastatin on hemorheological parameters in a rodent
traumatic brain injury model. The aggregation amplitude
first increased from the second day to the seventh day in
the sham-operated group; however, the aggregation index
remained stable on the seventh day. In the pravastatin
group, the aggregation amplitude significantly increased
on the 15th day, whereas the aggregation index remained
stable on the 15th day [31]. This finding indicates that the
aggregation amplitude should be taken into consideration
when evaluating the erythrocyte aggregation, especially
during the early stages of changes in the erythrocyte
aggregation.
There have been few studies on colloid concentrations
in plasma after hemorrhagic shock/resuscitation. The
final concentrations (1% and 1.5%) for HES that were
used in the present in vitro study were comparable to
values observed in clinical studies. It was reported that
patients undergoing orthopedic surgery have mean HES
plasma concentrations of approximately 1% at the end
of surgery [17]. During hemodilution therapy in patients
with cerebrovascular diseases, the mean HES plasma
peak concentration was 1.5% [18]. Therefore, the in vitro
data we present are likely to reflect clinical conditions
during large-dose colloid administration.
The plasma viscosity was significantly increased when
GEL was used compared with HES 130 and HES 200,
both in vitro and in vivo. However, the intrinsic viscosity
of GEL was lower than those of HES 130 and HES 200.
The various interactions between colloids and plasma
proteins may account for this result. Previous studies
have indicated that the solution viscosity increases with
the rise of molecular mass of a given type of colloid at a
constant concentration [32,33]. As mentioned above, gel-
atin has also been shown to interact specifically with
plasma proteins, such as fibronectin [34], and may there-
fore enhance the formation of macromolecules, leading to
increased plasma viscosity.
In our previous study, we compared the effects of
different solutions including HES 130, HES 200, GEL,
LR, normal saline, and Ringer acetate on hemorheol-
ogy in an in vitro study and found there were no signifi-
cant differences for hemorheological parameters between
isotonic crystalloids. Therefore, we finally chose LR as the
control in this study. In addition, the results in vitro are
not directly comparable with in vivo coagulation in rats.
For the ratio of 3:1 in vitro study, LR was indicated to
increase AI. There is no doubt that LR can decrease
plasma protein concentrations and plasma viscosity. The
decrease of plasma protein concentrations results in theinhibition of erythrocyte aggregation [35,36]. The result
in this study implies that other factors also were
involved in the increased erythrocyte aggregation. The
divalent cations (Ca+ +) contained in LR are indicated
to exacerbate the erythrocyte aggregation by decreasing
the erythrocyte surface potential and electric double layer
[37]. In addition, although it remains controversial, the
lactate level was positively correlated with erythrocyte
aggregation [38,39]. Consequently, the divalent cations
and lactate may account for the increased erythrocyte
aggregation.
A previous study has indicated that the pH levels can
affect the erythrocyte aggregation [40]. There is a huge
range from four different solutions (4.7–7.1). However,
we found that the pH level of blood samples showed
negligible changes when the samples mixed with four
different solutions. It is inferred that the buffering cap-
acity of the blood samples may prevent the pH levels
from changing. The pH levels did not account for the
difference of erythrocyte aggregation in this study.
The present study has limitations. First, the present
in vivo study examined only a single time point, i.e., 2 h
after treatment. Second, the results of blood gas and lac-
tate concentration were absent. In addition, the volume
of resuscitation was three times that of the blood with-
drawal for LR in this study. The volume may hyperinfuse
the rats, which may have an impact on the results.
Conclusions
In summary, our study indicates that different synthetic
colloids used for resuscitation produce various hemorheo-
logical effects, particularly with respect to erythrocyte ag-
gregation. We also determined that GEL significantly
accelerates the erythrocyte aggregation and significantly
elevates the plasma viscosity compared to hydroxyethyl
starch; furthermore, hydroxyethyl starch did not change
the erythrocyte aggregation compared to that of the con-
trol group. In addition, in vitro hemorheological measure-
ments are likely to provide hints for in vivo studies.
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